CCI approves merger of Shasun Pharma with Strides Arcolab

The combination of Strides and Shasun would create a company with a turnover of Rs 2,500 crore, placing the combined entity among the top 15 listed drug makersCCI gives green signal to merger of Shasun Pharma with Strides

Fair trade watchdog CCI has given its approval to the proposed merger of Chennai-based  Shasun Pharmaceuticals with drug maker Strides Arcolab .

"The proposed combination is not likely to have any appreciable adverse effect on competition in India and therefore, the Commission hereby approves the proposed combination," the Competition Commission of India (CCI) said in an order dated March 4. Under the proposed deal, Shasun will amalgamate with Strides in an all-stock transaction.

The combination of Strides and Shasun would create a company with a turnover of Rs 2,500 crore, placing the combined entity among the top 15 listed drug makers.

Shashun shareholders would receive 5 equity shares of Strides for every 16 shares held by them in Shasun. Based on the exchange ratio, Shasun shareholders would own 26 per cent of the combined entity.

Strides, a Bangalore-based firm develops and manufactures IP-led niche pharmaceutical products. It has 8 manufacturing facilities presence in more than 75 countries. Incorporated in 1976, Shasun is a global supplier of development and manufacturing services for intermediates, API and formulations to the pharmaceutical industry.

Shasun Pharma stock price

On March 24, 2015, at 11:10 hrs Shasun Pharmaceuticals was quoting at Rs 358.00, up Rs 13.60, or 3.95 percent. The 52-week high of the share was Rs 391.50 and the 52-week low was Rs 67.70.

The company's trailing 12-month (TTM) EPS was at Rs 7.57 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 47.29. The latest book value of the company is Rs 52.55 per share. At current value, the price-to-book value of the company is 6.81.

Anda sedang membaca artikel tentang

CCI approves merger of Shasun Pharma with Strides Arcolab

Dengan url

https://olahragakecantikan.blogspot.com/2015/03/cci-approves-merger-of-shasun-pharma.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

CCI approves merger of Shasun Pharma with Strides Arcolab

namun jangan lupa untuk meletakkan link

CCI approves merger of Shasun Pharma with Strides Arcolab

sebagai sumbernya